Table 1.
Patients Characteristics based on their baseline visit (angiography time)*
| All Patient (n = 1232) | Medical Treatment (n = 406) | PCI (n = 530) | CABG (n = 296) | P value | |
|---|---|---|---|---|---|
| Age (y) | 45.11±5.76 | 45.34±6.09 | 44.63±5.80 | 45.64±5.16 | 0.034 |
| Sex | 0.152 | ||||
| Male | 613 (49.8) | 187 (46.1) | 278 (52.5) | 148 (50.0) | |
| Female | 619 (50.2) | 219 (53.9) | 252 (47.5) | 148 (50.0) | |
| Risk Factors | |||||
| Positive Family History | 539 (43.8) | 168 (41.4) | 233 (44.0) | 138 (46.6) | 0.381 |
| Hypertension | 575 (46.7) | 214 (52.7) | 225 (42.5) | 136 (45.9) | 0.007 |
| Hyperlipidemia | 884 (71.8) | 279 (68.7) | 390 (73.6) | 215 (72.6) | 0.242 |
| Diabetes Mellitus | 390 (31.7) | 123 (30.3) | 162 (30.6) | 105 (35.5) | 0.268 |
| Cigarette Smoking | 0.457 | ||||
| Never Smoked | 753 (61.1) | 259 (63.8) | 309 (58.3) | 185 (62.5) | |
| Former Smokers | 93 (7.5) | 26 (6.4) | 45 (8.5) | 22 (7.4) | |
| Current Smokers | 386 (31.3) | 121 (29.8) | 176 (33.2) | 89 (30.1) | |
| Opium Usage | 160 (13.0) | 60 (14.8) | 58 (10.9) | 41 (13.9) | 0.175 |
| No Risk Factor | 41 (3.3) | 13 (3.2) | 20 (3.8) | 8 (2.7) | 0.702 |
| BMI (kg/m2) | 29.18±4.79 | 29.51±5.22 | 28.99±4.52 | 29.07±4.63 | 0.241 |
| BMI Categories | 0.185 | ||||
| Underweight | 12 (1.0) | 5 (1.2) | 5 (0.9) | 2 (0.7) | |
| Normal | 244 (19.9) | 85 (21.1) | 97 (18.3) | 62 (20.9) | |
| Overweight | 532 (43.3) | 153 (38.1) | 251 (47.4) | 128 (43.2) | |
| Obese | 440 (35.8) | 159 (39.6) | 177 (33.4) | 104 (35.1) | |
| Metabloic Syndrome | 590 (47.9) | 190 (32.2) | 248 (42.0) | 152 (25.8) | 0.932 |
| Triglyceride (mg/dl) | 203.37±127.17 | 193.16±110.12 | 207.14±138.40 | 210.47±127.45 | 0.309 |
| Cholesterol (mg/dl) | 196.51±51.67 | 195.48±50.33 | 194.17±53.30 | 202.21±50.16 | 0.092 |
| LDL (mg/dl) | 119.95±42.61 | 119.02±41.96 | 118.10±42.84 | 124.21±42.90 | 0.122 |
| HDL (mg/dl) | 41.09±11.01 | 42.25±11.27 | 40.37±10.95 | 40.75±10.67 | 0.036 |
| FBS (mg/dl) | 127.64±61.01 | 127.35±62.75 | 124.92±56.30 | 132.79±66.01 | 0.580 |
| Creatinine (mg/dl) | 0.97±0.44 | 1.00±0.70 | 0,.95±0.23 | 0.96±0.24 | 0.886 |
| EF (%) | 52.55±10.01 | 52.93±9.99 | 52.40±10.16 | 52.26±9.81 | 0.638 |
| Abdominal Circumference (cm) | 0.360 | ||||
| Male | 98.11±9.33 | 99.34±10.89 | 97.72±8.14 | 97.44±9.42 | |
| Female | 99.87±13.49 | 100.24±12.28 | 100.06±14.71 | 99.00±12.6 | |
| Blood Pressure (mmHg) | |||||
| Systolic | 127.16±18.23 | 128.82±17.01 | 125.30±19.11 | 128.59±17.79 | 0.028 |
| Diastolic | 80.88±18.58 | 81.76±11.13 | 81.21±25.02 | 79.09±9.64 | 0.293 |
| Heart Failure | 5 (0.4) | 2 (0.5) | 1 (0.2) | 2 (0.7) | 0.732 |
| Renal Failure | 6 (0.5) | 5 (1.3) | 0 | 1 (0.4) | 0.024 |
| Recent MI | 533 (45.6) | 167 (43.2) | 251 (49.5) | 117 (42.1) | 0.035 |
| No. of Involved Vessels | < 0.001 | ||||
| SVD | 559 (45.4) | 238 (58.6) | 286 (54.0) | 35 (11.8) | |
| 2VD | 342 (27.8) | 102 (25.1) | 166 (31.3) | 74 (25.0) | |
| 3VD | 331 (26.9) | 66 (16.3) | 78 (14.7) | 187 (63.2) | |
| Left Main Coronary Involvement | 22 (1.8) | 0 | 0 | 22 (7.4) | < 0.001 |
*
Data are presented as mean±SD or n (%)
PCI, Percutaneous coronary intervention; CABG, Coronary artery bypass grafting; BMI, Body mass index; LDL, Low-density lipoprotein; HDL, High-density lipoprotein; FBS, Fasting blood sugar; EF, Ejection fraction; MI, Myocardial infarction; SVD, Single-vessel disease; 2VD, Two-vessel disease; 3VD, Three-vessel disease